UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data

Magnetic resonance in medicine, 1997-09, Vol.38 (3), p.389-398

1997

Volltextzugriff (PDF)

Xenotransplantation of Porcine Fetal Ventral Mesencephalon in a Rat Model of Parkinson's Disease: Functional Recovery and Graft Morphology

Experimental neurology, 1996-07, Vol.140 (1), p.1-13

1996

Volltextzugriff (PDF)

Implanted Fibroblasts Genetically Engineered to Produce Brain-Derived Neurotrophic Factor Prevent 1-Methyl-4-Phenylpyridinium Toxicity to Dopaminergic Neurons in the Rat

Proceedings of the National Academy of Sciences - PNAS, 1994-05, Vol.91 (11), p.5104-5108

1994

Volltextzugriff (PDF)

Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain

Molecular pharmacology, 1991-02, Vol.39 (2), p.105-108

1991

Volltextzugriff (PDF)

NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease

Neuroreport, 1996-11, Vol.7 (15-17), p.2639-2642

1996

Volltextzugriff (PDF)

Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration

Cell transplantation, 1996-03, Vol.5 (2), p.225-232

1996

Volltextzugriff (PDF)

Clinimetric testing of the comprehensive cervical dystonia rating scale

Movement disorders, 2016-04, Vol.31 (4), p.563-569

2016

Volltextzugriff (PDF)

Interface between tauopathies and synucleinopathies: A tale of two proteins

Annals of neurology, 2006-03, Vol.59 (3), p.449-458

2006

Volltextzugriff (PDF)

Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alterations

The Journal of pharmacology and experimental therapeutics, 1990-07, Vol.254 (1), p.33

1990

Volltextzugriff (PDF)

Prenatal exposure to benzodiazepine. I, Prenatal exposure to lorazepam in mice alters open-field activity and GABAA receptor function

Neuropharmacology, 1991, Vol.30 (1), p.53-58

1991

Volltextzugriff (PDF)

Chronic benzodiazepine administration. VIII. Receptor upregulation produced by chronic exposure to the inverse agonist FG-7142

The Journal of pharmacology and experimental therapeutics, 1991-07, Vol.258 (1), p.280

1991

Volltextzugriff (PDF)

Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam

The Journal of pharmacology and experimental therapeutics, 1992-04, Vol.261 (1), p.285

1992

Volltextzugriff (PDF)

Benzodiazepine receptor binding of benzodiazepine hypnotics: Receptor and ligand specificity

Pharmacology, biochemistry and behavior, 1992-10, Vol.43 (2), p.413-416

1992

Volltextzugriff (PDF)

Effects of striatal excitotoxicity on Huntingtin-like immunoreactivity

Neuroreport, 1995-05, Vol.6 (8), p.1125-1129

1995

Volltextzugriff (PDF)

Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA‐receptor function

British journal of pharmacology, 1990-12, Vol.101 (4), p.839-842

1990

Volltextzugriff (PDF)

Cell-mediated delivery of neurotrophic factors and neuroprotection in the neostriatum and substantia nigra

Restorative neurology and neuroscience, 1995, Vol.8 (1,2), p.59-61

1995

Volltextzugriff (PDF)

Impulse Control Disorders in Parkinson’s Disease:Management, Controversies, and Potential Approaches

Movement disorders, 2015-01, Vol.30 (2), p.150-159

2015

Volltextzugriff (PDF)

Modification of γ‐Aminobutyric AcidA Receptor Binding and Function by N‐Ethoxycarbonyl‐2‐Ethoxy‐1,2‐Dihydroquinoline In Vitro and In Vivo: Effects of Aging

Journal of neurochemistry, 1991-04, Vol.56 (4), p.1241-1247

1991

Volltextzugriff (PDF)

Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABA A ‐receptor function

British journal of pharmacology, 1990-12, Vol.101 (4), p.839-842

1990

Volltextzugriff (PDF)

Chronic benzodiazepine administration: IX. Attenuation of alprazolam discontinuation effects by carbamazepine

Biochemical pharmacology, 1991-12, Vol.42, p.S99-S104

1991

Volltextzugriff (PDF)

Prenatal benzodiazepine administration. II. Lorazepam exposure is associated with decreases in [ 35S]TBPS binding but not benzodiazepine binding

Pharmacology, biochemistry and behavior, 1991-10, Vol.40 (2), p.429-432

1991

Volltextzugriff (PDF)

Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration

Psychopharmacology, 1991, Vol.104 (2), p.225-230

1991

Volltextzugriff (PDF)

Chronic benzodiazepine administration. VII : Behavioral tolerance and withdrawal and receptor alteractions associated with clonazepam administration

Psychopharmacologia, 1991, Vol.104 (2), p.225-230

1991

Volltextzugriff (PDF)

Interleukin-1 augments gamma -aminobutyric acid sub(A) receptor function in brain

Molecular pharmacology, 1991-01, Vol.39 (2), p.105-108

1991

Volltextzugriff (PDF)

Prenatal benzodiazepine administration. II. Lorazepam exposure is associated with decreases in ( super(35)S)TBPS binding but not benzodiazepine binding

Pharmacology, biochemistry and behavior, 1991-01, Vol.40 (2), p.429-432

1991

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data

Xenotransplantation of Porcine Fetal Ventral Mesencephalon in a Rat Model of Parkinson's Disease: Functional Recovery and Graft Morphology

Implanted Fibroblasts Genetically Engineered to Produce Brain-Derived Neurotrophic Factor Prevent 1-Methyl-4-Phenylpyridinium Toxicity to Dopaminergic Neurons in the Rat

Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain

NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease

Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration

Clinimetric testing of the comprehensive cervical dystonia rating scale

Interface between tauopathies and synucleinopathies: A tale of two proteins

Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alterations

Prenatal exposure to benzodiazepine. I, Prenatal exposure to lorazepam in mice alters open-field activity and GABAA receptor function

Chronic benzodiazepine administration. VIII. Receptor upregulation produced by chronic exposure to the inverse agonist FG-7142

Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam

Benzodiazepine receptor binding of benzodiazepine hypnotics: Receptor and ligand specificity

Effects of striatal excitotoxicity on Huntingtin-like immunoreactivity

Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA‐receptor function

Cell-mediated delivery of neurotrophic factors and neuroprotection in the neostriatum and substantia nigra

Impulse Control Disorders in Parkinson’s Disease:Management, Controversies, and Potential Approaches

Modification of γ‐Aminobutyric AcidA Receptor Binding and Function by N‐Ethoxycarbonyl‐2‐Ethoxy‐1,2‐Dihydroquinoline In Vitro and In Vivo: Effects of Aging

Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABA A ‐receptor function

Chronic benzodiazepine administration: IX. Attenuation of alprazolam discontinuation effects by carbamazepine

Prenatal benzodiazepine administration. II. Lorazepam exposure is associated with decreases in [ 35S]TBPS binding but not benzodiazepine binding

Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration

Chronic benzodiazepine administration. VII : Behavioral tolerance and withdrawal and receptor alteractions associated with clonazepam administration

Interleukin-1 augments gamma -aminobutyric acid sub(A) receptor function in brain

Prenatal benzodiazepine administration. II. Lorazepam exposure is associated with decreases in ( super(35)S)TBPS binding but not benzodiazepine binding

Suchergebnisse filtern